Volume 6.26 | Jul 10

Mammary Cell News 6.26 July 10, 2014
Mammary Cell News
     In this issue: Publications | Reviews | Industry News | Policy News | Events | Jobs
Cell Therapy News on Facebook  Mammary Cell News on Twitter
Protein Pushes Breast Cancer Cells to Metastasize
Using an innovative tool that captures heretofore hidden ways that cells are regulated, scientists have identified a protein that makes breast cancer cells more likely to metastasize. In cells prone to metastasis, they found certain RNA hairpin loops that were overrepresented in the sequences of RNAs targeted for destruction. [Press release from the Rockefeller University (EurekAlert!) discussing online prepublication in Nature]
Press Release | Abstract
[Free On-Demand Webinar] Detect Cancer Stem Cells with ALDEFLUOR™ - Watch Now.
PUBLICATIONS (Ranked by impact factor of the journal)

Spatial Control of Membrane Receptor Function Using Ligand Nanocalipers
Scientists developed rationally designed DNA origami nanostructures modified with ligands at well-defined positions. Using these ‘nanocalipers’ to present ephrin ligands, they showed that the nanoscale spacing of ephrin-A5 directs the levels of EphA2 receptor activation in human breast cancer cells. [Nat Methods]
Abstract | Press Release

Therapeutic Targeting of Integrin αvβ6 in Breast Cancer
Using antibody blockade and siRNA knockdown of integrin subunit beta6 (β6) in breast cell lines, the role of αvβ6 in human epidermal growth factor receptor 2 biology (expression, proliferation, invasion, growth in vivo) was assessed by flow cytometry, MTT, Transwell invasion, proximity ligation assay, and xenografts, respectively. [J Natl Cancer Inst] Abstract | Full Article | Press Release

Inhibition of BMP Signaling Suppresses Metastasis in Mammary Cancer
Investigators show that human breast cancers display active bone morphogenetic protein (BMP) signaling, which is rarely downregulated or homozygously deleted. They used DMH1, a BMP antagonist, in MMTV.PyVmT expressing mice. Treatment with DMH1 reduced lung metastasis and the tumors were less proliferative and more apoptotic. [Oncogene] Abstract

Sequencing of Breast Cancer Stem Cell Populations Indicates a Dynamic Conversion between Differentiation States In Vivo
Researchers undertook exome sequencing of cancer stem-like cells (CSCs) from 12 breast cancer patients, along with paired primary tumor samples. Their analysis revealed that the majority of somatic mutations are shared between CSCs and bulk primary tumor, with similar frequencies in the two. [Breast Cancer Res] Abstract | Full Article

Circulating Cell-Free Cancer-Testis MAGE-A RNA, BORIS RNA, let-7b and miR-202 in the Blood of Patients with Breast Cancer and Benign Breast Diseases
The serum levels of melanoma-associated antigen-A (MAGE-A) and BORIS mRNA, as well as let-7b were significantly higher in patients with invasive carcinomas than in patients with benign breast diseases or healthy women, whereas the levels of miR-202 were elevated in both patient cohorts. [Br J Cancer] Abstract

Emerging Role of Long Non-Coding RNA SOX2OT in SOX2 Regulation in Breast Cancer
Researchers show that the expression of SOX2 and SOX2 overlapping transcript (SOX2OT) is concordant in breast cancer, differentially expressed in estrogen receptor positive and negative breast cancer samples and that both are up-regulated in suspension culture conditions that favor growth of stem cell phenotypes. [PLoS One] Full Article

Morin, a Flavonoid from Moraceae, Suppresses Growth and Invasion of the Highly Metastatic Breast Cancer Cell Line MDA-MB‑231 Partly through Suppression of the Akt Pathway
Researchers investigated the anticancer effects of morin on highly metastatic human breast cancer cells. Results showed that morin significantly inhibited the colony forming ability of highly metastatic MDA-MB‑231 breast cancer cells from low doses (50 μM) without cytotoxicity. [Int J Oncol] Abstract

Retroviral-Infection Increases Tumorigenic Potential of MDA-MB-231 Breast Carcinoma Cells by Expanding an Aldehyde Dehydrogenase (ALDH1) Positive Stem-Cell Like Population
Scientists demonstrate that transduction of human breast carcinoma cells (MDA-MB231) with LXSN and QCXIP retroviral vectors causes significant increases in growth rate, clonogenic fraction, and ALDH1 positive cells, which is associated with increased steady-state levels of cancer stem cell populations. [Redox Biol] Full Article


Feasibility Study of Personalized Peptide Vaccination for Metastatic Recurrent Triple-Negative Breast Cancer Patients
Scientists developed a novel regimen of personalized peptide vaccination (PPV), in which vaccine antigens are individually selected from a pool of different peptide candidates based on the pre-existing host immunity. They conducted a Phase II study of PPV for metastatic recurrent breast cancer patients to investigate the feasibility of PPV for metastatic recurrent triple-negative breast cancer. [Breast Cancer Res] Abstract | Full Article

TBCRC 018: Phase II Study of Iniparib in Combination with Irinotecan to Treat Progressive Triple Negative Breast Cancer Brain Metastases
Investigators evaluated the safety and efficacy of iniparib, a small molecule anti-cancer agent that alters reactive oxygen species tumor metabolism and penetrates the blood brain barrier, with the topoisomerase I inhibitor irinotecan in patients with triple negative breast cancer brain metastases. [Breast Cancer Res Treat]

Learn More: Column-Free Enrichment of Mouse Mammary Stem & Progenitor Cells
Breast Cancer Stem Cells and the Immune System: Promotion, Evasion and Therapy
Components of both the adaptive and the innate immune system have been shown to play a crucial role in supporting breast cancer growth and spread, and recently some immune mediators, both molecules and cells, have been reported to influence breast cancer stem cell biology. The authors summarize a small, pioneering body of evidence for the potentially important function of the “immuniche” in maintaining and supporting breast cancer stem cells. [J Mammary Gland Biol Neoplasia] Abstract

Visit our reviews page to see a complete list of reviews in the mammary cell research field.
BeiGene Enrolls First Patient in Phase I Study of BGB-290
BeiGene Co., Ltd. has dosed the first patient in a Phase I study of BGB-290 for the treatment of cancer. BGB-290 is an investigational, oral, selective and potent inhibitor of poly (ADP-ribose) polymerase, an enzyme family which is involved in a number of cellular processes, including DNA repair and programmed cell death. [BeiGene Co., Ltd.] Press Release

Compugen Discloses Achievement of Milestone in Cancer Immunotherapy Collaboration with Bayer
Compugen Ltd. disclosed that it has achieved the initial milestone in the cancer immunotherapy collaboration it entered with Bayer HealthCare. The collaboration provides for the development and commercialization of therapeutic antibodies against two checkpoint protein candidates discovered by Compugen. [Compugen Ltd.] Press Release

From our sponsor:
Interested in assays for human mammary stem and progenitor cells?
Request your free wallchart.
National Institutes of Health (United States)

Food and Drug Administration (United States)

Center for Biologics Evaluation and Research (United States)

European Medicines Agency (European Union)

Medicines and Healthcare Products Regulatory Agency (United Kingdom)

Therapeutic Goods Administration (Australia)
NEW FEBS-EMBO 2014 Conference
August 30 – September 4, 2014
Paris, France

Visit our events page to see a complete list of events in the mammary cell community.
NEW Postdoctoral Fellow – Molecular Cancer Biology (University of Texas Health Science Center at San Antonio)

NEW Postdoctoral Position – Breast Cancer Research (University of Oklahoma Health Sciences Center)

PhD Candidate – Mammary Stem Cell Biology (University of Amsterdam)

Postdoctoral Fellow – Breast Cancer Biology (University of Tennessee Health Science Center)

Postdoctoral Associates – Morphogenesis of the Mammary Gland (Princeton University)

Postdoctoral Candidates – Cell Biology (Albert Einstein College of Medicine)

Postdoctoral Scholar – Cancer and RNA Research (Northwestern University)

Postdoctoral Research Associates – Pattern Formation during Branching Morphogenesis of the Mammary Gland (Princeton University)

Postdoctoral Position – Breast Cancer Metastasis (Weizmann Institute of Science)

Scientist – Mammary Cell Research (STEMCELL Technologies Inc.)

Scientist – Pluripotent Stem Cell Media Development, High Throughput Screening (STEMCELL Technologies Inc.)

Scientist – Cell Culture Support Products (STEMCELL Technologies Inc.)

Scientist – Immunology/Cell Separation (STEMCELL Technologies Inc.)

Research Associate – Cell Separation (STEMCELL Technologies Inc.)

Recruit Top Talent: Reach more than 50,000 potential candidates by posting your organization’s career opportunities on the Connexon Creative Job Board at no cost.

Have we missed an important article or publication in Mammary Cell News? Click here to submit!

Comments or suggestions? Submit your feedback here
Learn more about Mammary Cell News: Archives | Events | Contact Us